What This Treatment Is
Opioid MAT is Medication-Assisted Treatment specifically for opioid use disorder (OUD). It combines FDA-approved medications with counseling and behavioral therapy, and it’s the standard of care for OUD per SAMHSA guidance. For Calabasas residents, our program runs from the Woodland Hills campus — a short commute north via US-101 with telehealth follow-up available.
Medications Used for OUD
Buprenorphine (a partial opioid agonist, delivered as Suboxone or monotherapy) reduces cravings and withdrawal. Naltrexone (a full opioid antagonist) blocks opioid effects — available as a daily oral tablet or a monthly injection (Vivitrol). Methadone requires a federally certified Opioid Treatment Program (OTP); we refer to a certified OTP when methadone is the clinical fit and continue therapy and psychiatric care with our team.
Why Medication Matters for OUD
Opioid use disorder produces measurable neurobiologic changes that persist after the drug is gone. Medication stabilizes cravings and withdrawal so therapy can do the work of building durable recovery. Peer-reviewed research consistently shows MAT reduces overdose mortality and improves retention compared with therapy alone.
Our Care Model: Specialty-Led, Distinct Primary Tracks
Elevated Healing operates separate primary treatment tracks for Mental Health and Substance Use, each led by the appropriate clinical specialty from day one. When both are present, our teams coordinate care across tracks so the full clinical picture is addressed without collapsing treatment into a single generalized program.
This is different from a blended or generalized model. Read more on our Care Model page.
Elevated Healing’s Specialty-Led Approach
Our team treats opioid use disorder as its own primary track under board-certified psychiatric leadership. For Calabasas patients, care is designed to fit the reality of a commute and a schedule — without diluting clinical rigor.
The process:
- Full psychiatric and substance use evaluation on-site at Woodland Hills campus.
- Medication selection: buprenorphine, oral naltrexone, or Vivitrol (or referral to OTP for methadone).
- Induction planned in person at Woodland Hills to avoid precipitated withdrawal.
- Concurrent therapy: CBT, DBT, EMDR, ART — often available via telehealth once you’re stable.
- Regular follow-up: weekly early, monthly once stable, most visits eligible for video.
- Coordinated psychiatric care when mental health conditions co-occur.
Access from Calabasas
Our physical location is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, about a 15-minute drive from Calabasas via US-101 in normal traffic.
- From central Calabasas — US-101 East, exit at Winnetka Avenue or De Soto Avenue, then a short drive north.
- From Hidden Hills or Woodland Hills-adjacent areas — many patients complete the trip in under 15 minutes.
- From Agoura Hills or Westlake Village — allow about 20–25 minutes via US-101.
- Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video across California, reducing travel burden for maintenance and step-down care.
New patients typically complete their initial evaluation in person; ongoing follow-up can be scheduled remotely when clinically appropriate.
Program Levels That Deliver This Care
This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.
Partial Hospitalization (PHP)
Structured day program, five days per week, with psychiatric oversight and integrated therapy.
Learn about PHPIntensive Outpatient (IOP)
Three-to-five sessions per week that allow work or school to continue.
Learn about IOPOutpatient (OP)
Weekly therapy plus regular psychiatric visits — well-suited to step-down maintenance.
Learn about OPTelehealth Follow-Up
Video visits with the psychiatric provider, available across California for eligible patients.
Learn about telehealthInsurance, Cost, and Getting Started
Most commercial insurance plans cover opioid mat under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.
The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:
- Verify your insurance benefits within one business day.
- Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
- Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
- Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.
If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.
What Progress Looks Like
Recovery through opioid mat is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.
Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.
Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.
Confidentiality and HIPAA Protections
Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).
Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.
Frequently Asked Questions
Which OUD medication is right for me?
How does the Calabasas commute affect treatment?
What if I've tried MAT before and it didn't work?
Will I be able to work or run my business on MAT?
What if I relapse while on MAT?
Does insurance cover opioid MAT?
If You’re in Crisis
If you or someone you love is in immediate crisis, help is available 24/7. You are not alone.
- 988 Suicide & Crisis Lifeline — Call or text 988 (24/7, free, confidential)
- SAMHSA National Helpline — 1-800-662-HELP (4357) — mental health & substance use referrals
- The Trevor Project — 1-866-488-7386 — LGBTQ+ youth crisis support
Trusted External Resources
Independent, evidence-based sources on the topics covered on this page:
Federal public health agency’s clinical overview of MAT for opioid use disorder.
NIH institute research on opioid use disorder, treatment, and prevention.
FDA drug information on buprenorphine, naltrexone, and other OUD medications.
APA’s public-facing guidance on substance use disorders.
Municipal resources and community services for Calabasas.
Ready to Talk About Opioid MAT?
Our admissions team can walk you through what treatment looks like, verify insurance benefits, and answer questions. Conversations are confidential.
Call us confidentially at (747) 888-3000 — or request a consultation online.
Schedule Your Consultation